State of Tennessee, Department of Treasury
Position in HALO — Halozyme Therapeutics, Inc.
CIK 1587973
NASHVILLE, TN
Position in HALO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,717,259
-$153,567 QoQ
Shares Held
57,516
0.0% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026State of Tennessee, Department of Treasury holds $125,190,066 across 33 Biotechnology names. HALO ranks #6 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
81,668 | $36,468,028 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
41,458 | $32,032,109 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
29,581 | $5,592,288 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
91,261 | $5,155,333 | |
| 5 | EXEL |
Exelixis, Inc.
|
119,701 | $5,133,975 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
This page
|
57,516 | $3,717,259 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
129,274 | $3,580,889 | |
| 8 | INCY |
Incyte Corp
|
37,020 | $3,484,322 |
All Filings in HALO
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,717,259 | 57,516 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,870,826 | 57,516 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $3,037,082 | 41,411 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,543,394 | 68,116 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $4,059,656 | 63,621 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,802,670 | 58,621 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,450,141 | 60,275 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,389,158 | 64,728 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,959,311 | 48,164 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,780,141 | 48,164 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,916,264 | 50,164 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,557,146 | 70,894 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $3,216,514 | 84,224 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $7,727,702 | 135,812 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $5,370,006 | 135,812 | Shares | Sole | 2023-01-26 | |
| 2022-06-30 | $5,544,396 | 126,009 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,632,438 | 66,009 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $2,252,121 | 56,009 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $2,278,446 | 56,009 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,796,665 | 61,587 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $5,902,762 | 141,587 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $4,698,100 | 110,000 | Shares | Sole | 2021-02-09 | |
| No filing history on record for this holder in this stock. | ||||||